Inventor · disambiguated record
Dean Ng
Also filed as: NG DEAN
4 granted patents·11 pending applications·30 citations·filing 2004–2023
75Inventor score
Top patents by PatentIndex Score
15 records- 0196US10899835B2IgM Fc and J-chain mutations that affect IgM serum half-lifeIGM BIOSCIENCES INC·Filed 2020·Granted Jan 26, 2021·7 cites·28 claims
- 0293US10604559B2Multi-valent hepatitis B virus antigen binding molecules and uses thereofIGM BIOSCIENCES INC·Filed 2016·Granted Mar 31, 2020·15 cites·18 claims
- 0390US11535664B2Multi-valent hepatitis B virus antigen binding molecules and uses thereofIGM BIOSCIENCES INC·Filed 2020·Granted Dec 27, 2022·2 cites·19 claims
- 0490US11401337B2Modified human IgM constant regions for modulation of complement-dependent cytolysis effector functionIGM BIOSCIENCES INC·Filed 2018·Granted Aug 2, 2022·6 cites·36 claims
- 0579US2024124584A1Igm fc and j-chain mutations that affect igm serum half-lifeIGM BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 0669US2022403009A1Multimeric coronavirus binding molecules and uses thereofIGM BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 0767US2022340676A1Modified human igm constant regions for modulation of complement-dependent cytolysis effector functionIGM BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 0866US2021087273A1IgM Fc AND J-CHAIN MUTATIONS THAT AFFECT IgM SERUM HALF-LIFEIGM BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 0964US2023058162A1Multimeric coronavirus binding molecules and uses thereofIGM BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 1056US2022267415A1Multimeric sars-cov-2 binding molecules and uses thereofUNIV TEXAS·Filed 2022·Application pending·0 cites
- 1152US2022306760A1Igm glycovariantsIGM BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 1250US2021380701A1MULTIVALENT IgM- AND IgA-Fc-BASED BINDING MOLECULESIGM BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 1345US2023203119A1Immunostimulatory multimeric binding moleculesIGM BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 1443US2005003390A1Targets for controlling cellular growth and for diagnostic methodsFiled 2004·Application pending·0 cites
- 1537US2010331397A12-5a analogs and their methods of useALIOS BIOPHARMA INC·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →